Sibylle C Mellinghoff Kanika Vanshylla Christine Dahlke Marylyn M Addo Oliver A Cornely Florian Klein Thorsten Persigehl Jan Rybniker Henning Gruell Paul J Bröckelmann
10.3389/fimmu.2021.798276
Front Immunol
2021 Dec 20;12:798276.
covid-19 nsclc sars-cov-2 anti-pd1 immune checkpoint immunotherapy pneumonitis
CC BY
https://pubmed.ncbi.nlm.nih.gov/34987520/
Adrenal Cortex Hormones / therapeutic use COVID-19 Drug Treatment Carcinoma, Non-Small-Cell Lung / drug therapy Immune Checkpoint Inhibitors / therapeutic use Lung Neoplasms / drug therapy SARS-CoV-2 / drug effects
Adrenal Cortex Hormones / therapeutic use COVID-19 Drug Treatment Carcinoma, Non-Small-Cell Lung / drug therapy Immune Checkpoint Inhibitors / therapeutic use Lung Neoplasms / drug therapy SARS-CoV-2 / drug effects Case Reports Research Support, Non-U.S. Gov't Adult CD8-Positive T-Lymphocytes / drug effects CD8-Positive T-Lymphocytes / immunology CD8-Positive T-Lymphocytes / virology COVID-19 / complications COVID-19 / immunology COVID-19 Vaccines / administration & dosage COVID-19 Vaccines / immunology Carcinoma, Non-Small-Cell Lung / complications Carcinoma, Non-Small-Cell Lung / immunology Humans Immunity, Humoral / drug effects Immunity, Humoral / immunology Lung Neoplasms / complications Lung Neoplasms / immunology Male Neoplasm Metastasis Pneumonia / immunology Pneumonia / prevention & control Pneumonia / virology SARS-CoV-2 / immunology Adrenal Cortex Hormones COVID-19 Vaccines Immune Checkpoint Inhibitors
PMC8721042
34987520
Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19
2021